Patents Assigned to Deciphera Pharmaceuticals, LLS
  • Patent number: 8569319
    Abstract: Compounds useful in the treatment of mammalian cancers and especially human cancers according to Formula I are disclosed. Pharmaceutical compositions and methods of treatment employing the compounds disclosed herein are also disclosed.
    Type: Grant
    Filed: April 29, 2011
    Date of Patent: October 29, 2013
    Assignee: Deciphera Pharmaceuticals, LLS
    Inventors: Daniel L. Flynn, Michael D. Kaufman